1. Pink Sheet

US FDA Regulatory Affairs Reorg To Include Inspectors Trained In Real-World Evidence, Califf Says

 
• By Kate Rawson

The US FDA Commissioner acknowledged that the inspectorate has not been prepared for RWE, but as part of the revamp, a dedicated team will encourage its use “when it’s appropriate.”

health data
RWE training for FDA inspectors should help encourage sponsors to use the data, FDA Commissioner Robert Califf said. • Source: Shutterstock

The planned reorganization of the US Food and Drug Administration’s Office of Regulatory Affairs will include a program to train an inspection team to evaluate real-world evidence in the hopes of encouraging drug developers to use it, Commissioner Robert Califf said during an 11 September Friends of Cancer Research meeting.

Califf said “90-plus percent” of the inspectorate’s work “is either manufacturing or traditional clinical trials,” which he said, “goes extremely well

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Real-World Evidence

More from Clinical Trials